8 Results for "

cytochrome P450s

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "cytochrome P450s" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-117026
CAS No.: 1954681-29-8
Purity:  99.94%
LKY-047, a Decursin derivative, is a potent and selective reversible competitive cytochrome P45022J2 (CYP2J2) inhibitor with an IC50 of 1.7 μM. LKY-047 is inactive against other human P450s, such as CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A .
loading...
    loading...
Cat. No.: HY-16670
CAS No.: 1065506-69-5
Target:  

Cytochrome P450

Research Areas:  

Infection Cancer

Dafadine-A is a selective inhibitor of DAF-9 cytochrome P450 in the nematode Caenorhabditis elegans. Dafadine-A inhibits the mammalian ortholog of DAF-9 (CYP27A1). Dafadine-A does not inhibits DAF-12 and sterol- and oxysterol-metabolizing P450s .
loading...
    loading...
Cat. No.: HY-164793
CAS No.: 733806-89-8
Research Areas:  

Infection

TGFBR1-IN-2 (Compound AQA) is a TGFBR1 inhibitor and an antibacterial agent. TGFBR1-IN-2 is a substrate for cytochrome P450s. TGFBR1-IN-2 contains the pyridyl-6-methyl moiety necessary for Mycobacterium tuberculosis inhibition and has potent inhibitory activity against non-replicating and persistent Mycobacterium tuberculosis .
loading...
    loading...
Cat. No.: HY-14205
CAS No.: 911290-35-2
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

NW-1772 (methanesulfonate) (compound 22b) is a potent and selective monoamine oxidase (MAO) B inhibitor. NW-1772 has some advantages, such as rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity. NW-1772 can be used for the research of neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-164510
CAS No.: 14686-61-4
Target:  

Cytochrome P450

Research Areas:  

Others

N-Formyldemecolcine is a colchicine precursor that contains the characteristic tropolone ring and pharmacophore of colchicine. N-Formyldemecolcine can be synthesized de novo by genetically engineering transgenic Nicotiana benthamiana and atypical cytochrome P450s that catalyze the production of colchicine's unique carbon scaffold .
loading...
    loading...
Cat. No.: HY-115824
CAS No.: 1370702-83-2
Target:  

Cytochrome P450

Research Areas:  

Others

7ETMC is a cytochrome P450 inhibitor with selective inhibition of human cytochrome P450s 1A1 and 1A2. 7ETMC has inhibitory effects on P450s 1A1 and 1A2 with IC?? values of 0.46μM and 0.50μM, respectively, within the first six minutes, and has no inhibitory activity against P450s 2A6 and 2B1. Except for 7-ethynyl-3-methyl-4-phenylcoumarin, the remaining inhibitors show mechanism-based inhibition of P450s 1A1 and 1A2.
loading...
    loading...
Cat. No.: HY-135073
CAS No.: 1934-63-0
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

PCMPA hydrochloride a derivative of Phencyclidine that can be metabolized by cytochrome P450 isoenzymes (P450s) .
loading...
    loading...
Cat. No.: HY-111156
CAS No.: 911290-20-5
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

NW-1172 (free base) (compound 22b) is a 5-HT3 receptor antagonist with performance-enhancing activity in a delayed matching task in monkeys, with the (R) isomer producing more systematic improvements than the (S) isomer, a difference paralleled by the higher affinity of the (R) enantiomer for the 5-HT3 receptor.
loading...
    loading...